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α-Synuclein (αS) is a presynaptic protein whose aggregation is associated with
Parkinson’s disease (PD). Although the physiological function of αS is still unclear,
several lines of evidence indicate that this protein may play a role in the trafficking of
synaptic vesicles (SVs) during neurotransmitter release, a task associated with its ability
to bind SVs and promote their clustering. It is therefore crucial to identify the cellular
factors that modulate this process. To address this question, using nuclear magnetic
resonance (NMR) spectroscopy we have characterized the role of cholesterol, a major
component of the membrane of SVs, in the binding of αS with synaptic-like vesicles.
Our results indicate that cholesterol can act as a modulator of the overall affinity of
αS for SVs by reducing the local affinity of the region spanning residues 65–97 in the
non-amyloid-β component (NAC) of the protein. The increased population of bound
states that expose the region 65–97 to the solvent was found to induce stronger vesicle-
vesicle interactions by αS. These results provide evidence that cholesterol modulates the
clustering of synaptic vesicles induced by (α)S, and supports the role of the disorder-to-
order equilibrium of the NAC region in the modulation of the biological properties of the
membrane-bound state of αS.
Keywords: α-synuclein, synaptic vesicles, membrane interaction, cholesterol, nuclear magnetic resonance
INTRODUCTION
α-Synuclein (αS) is a 140-residue protein primarily expressed in neuronal cells, where it localizes
predominantly at the pre-synaptic termini (Jakes et al., 1994). The aggregation of αS is linked
with Parkinson’s disease (PD), with its aggregates being a major component of Lewy bodies in PD
patients (Uversky and Eliezer, 2009; Luk et al., 2012; Lashuel et al., 2013; Chiti and Dobson, 2017;
Fusco et al., 2017). Genetic links also exist between αS and PD, with point mutations, duplication
and triplications in the αS encoding gene being associated with familial forms of the disease
(Polymeropoulos et al., 1997; Kruger et al., 1998; Singleton et al., 2003; Zarranz et al., 2004; Appel-
Cresswell et al., 2013; Lesage et al., 2013). αS aggregates have been found in other neurodegenerative
disorders, including Alzheimer’s disease (Lewis et al., 2010), dementia with Lewy bodies (Galvin
et al., 1999), multiple system atrophy (Spillantini et al., 1998), and other synucleinopathies
(Chiti and Dobson, 2017). Despite the general consensus on the pathological relevance of αS
aggregation, the function of this protein remains highly debated (Burre, 2015). A number of
experimental observations indicate a physiological interaction between αS and synaptic vesicles
(SVs), which has been associated with the regulation of SVs trafficking at the synaptic termini,
including the assistance of the formation of the SNARE complex during neurotransmitter release
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(Burre et al., 2010, 2014). It has also been suggested that αS
might be involved in the maintenance of pools of SVs at the
synapses (Cooper et al., 2006; Wislet-Gendebien et al., 2006;
Auluck et al., 2010; Nemani et al., 2010; Vargas et al., 2014), a role
that is associated with its ability to mediate interactions between
SVs (Gitler et al., 2008; Soper et al., 2008; Diao et al., 2013;
Fusco et al., 2016b). A common characteristics of the majority
of the putative functions so far proposed for αS – including
SV trafficking (Wislet-Gendebien et al., 2006; Gitler et al., 2008;
Soper et al., 2008; Auluck et al., 2010; Burre et al., 2010, 2014; Diao
et al., 2013), ER-to-Golgi vesicle trafficking (Cooper et al., 2006;
Gitler et al., 2008), mitochondrial binding (Zigoneanu et al., 2012;
Maltsev et al., 2013; Menges et al., 2017) – involves the binding
with biological membranes (Zigoneanu et al., 2012; Maltsev et al.,
2013; Snead and Eliezer, 2014). Indeed, the partition between
membrane bound and unbound states of αS appears to be
highly regulated in vivo (Lee et al., 2002) and influences its
aggregation propensity (Perrin et al., 2001; Necula et al., 2003;
Sharon et al., 2003; Zhu and Fink, 2003; Auluck et al., 2010;
Comellas et al., 2012).
Understanding the mechanism of interaction of αS with lipid
membranes and the conformational properties of its bound state
is therefore crucial to clarify the balance between functional
and dysfunctional forms of this protein. The significant levels of
structural disorder in both bound and unbound states, however,
pose significant experimental challenges in characterizing this
mechanism. Upon lipid membrane binding, αS undergoes a
transition from an intrinsically disordered protein to a partially
α-helical state that retains a significant level of structural disorder
(Eliezer et al., 2001; Ulmer and Bax, 2005; Bodner et al., 2009;
Maltsev et al., 2012). The α-helical segments in the membrane-
bound αS are promoted by seven imperfect sequence repeats in
the region 1–90 that encode for amphipathic α-helices (Eliezer
et al., 2001). The modular organization of these repeats enables
the binding of αS with a variety of lipid membranes, ranging from
lipid micelles to lipid vesicles and cellular membranes (Ulmer and
Bax, 2005; Ulmer et al., 2005; Jao et al., 2008; Bodner et al., 2009),
and via a multiplicity of distinct binding modes (Bodner et al.,
2009), including a broken (Ulmer and Bax, 2005; Ulmer et al.,
2005) and an extended α-helix (Jao et al., 2008; Lokappa and
Ulmer, 2011; Cheng et al., 2013). Several studies have indicated
that the binding of αS involves an initial membrane interaction by
the N-terminal 25 residues in an α-helical conformation (Fusco
et al., 2016a) and the cooperative propagation of the α-helical
structure throughout the central region (residues 26–97), while
the C-terminal region of the protein remains essentially unbound
to the membrane surface (Figure 1A; Bodner et al., 2009; Fusco
et al., 2014). Membrane binding by αS can also be influenced by a
variety of factors, including the properties of the membrane such
as charge, defects, curvature, lipid rafts, and the properties of αS
such as point mutations (Bodner et al., 2010; Fusco et al., 2016b)
and post-translational modifications (Fauvet et al., 2012). The
sensitivity of the binding modes to even relatively minor external
factors has therefore prompted a number of studies to investigate
the lipid membrane interaction by αS under conditions that
reproduce as closely as possible the physiological context in which
αS is present.
In this work, we characterized the role of cholesterol in the
interaction between αS and synaptic-like vesicles using nuclear
magnetic resonance (NMR) spectroscopy and other biophysical
techniques. Cholesterol is a key component of SVs, accounting
of 31% w/w of their total membrane composition (Takamori
et al., 2006). Our study found that the overall membrane-binding
affinity of αS for synaptic-like vesicles is substantially reduced in
the presence of cholesterol, with major effects occurring primarily
in the region spanning residues 65–97. Our data are discussed
in view of the mechanism by which αS can induce vesicle-
vesicle interactions (Fusco et al., 2016b), a property that has
been associated with the maintenance of SVs homeostasis during
neurotransmitter release.
MATERIALS AND METHODS
αS Purification
α-Synuclein was expressed and purified as previously described
(Fusco et al., 2014). Briefly the protein was expressed in
E. coli using plasmid pT7-7. After transforming in BL21 (DE3)-
gold cells (Agilent Technologies, Santa Clara, United States),
uniformly 15N and/or 13C labeled αS variants were obtained
by growing the bacteria in isotope-enriched M9 minimal media
containing 1 g.L−1 of 15N ammonium chloride, 2 g.L−1 of 13C-
glucose (Sigma-Aldrich, St. Louis, United States). The growth
was obtained at 37◦C under constant shaking at 250 rpm and
supplemented with 100 µg.ml−1 ampicillin to an OD600 of
0.6. The expression was induced with 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) at 37◦C for 4 h, and the cells
were harvested by centrifugation at 6200 g (Beckman Coulter,
Brea, United States). The cell pellets were resuspended in lysis
buffer (10 mM Tris–HCl pH 8, 1 mM EDTA, and EDTA-
free complete protease inhibitor cocktail tablets obtained from
Roche, Basel, Switzerland) and lysed by sonication. The cell
lysate was centrifuged at 22,000 g for 30 min to remove cell
debris. In order to precipitate the heat-sensitive proteins, the
supernatant was then heated for 20 min at 70◦C and centrifuged
at 22,000 g. Subsequently streptomycin sulfate was added to the
supernatant to a final concentration of 10 mg.ml−1 to stimulate
DNA precipitation. The mixture was stirred for 15 min at
4◦C followed by centrifugation at 22,000 g. Then, ammonium
sulfate was added to the supernatant to a concentration of
360 mg.ml−1 in order to precipitate the protein. The solution
was stirred for 30 min at 4◦C and centrifuged again at
22,000 g. The resulting pellet was resuspended in 25 mM
Tris–HCl, pH 7.7 and dialyzed against the same buffer in
order to remove salts. The dialyzed solutions were then loaded
onto an anion exchange column (26/10 Q sepharose high
performance, GE Healthcare, Little Chalfont, United Kingdom)
and eluted with a 0–1 M NaCl step gradient, and then further
purified by loading onto a size exclusion column (Hiload 26/60
Superdex 75 preparation grade, GE Healthcare, Little Chalfont,
United Kingdom). All the fractions containing the monomeric
protein were pooled together and concentrated by using Vivaspin
filter devices (Sartorius Stedim Biotech, Göttingen, Germany).
The purity of the aliquots after each step were analyzed by
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FIGURE 1 | Binding of αS to acidic SUVs. (A) Three regions of αS were found to have specific structural and dynamical properties at the surface of SUV-0% (Fusco
et al., 2014). These include the N-terminal anchor (residues 1–25, blue), whose ssNMR resonances spanning the region 6–25 were previously assigned (Fusco et al.,
2014), the central sensor region (residues 26–97, gray), and the C-terminal domain (residues 98–140, red) remaining essentially unbound and disordered at the
membrane surface. (B–E) CD measurements of αS binding to acidic SUV-0% (B,D) and SUV-31% (C,E). In all measurements the concentration of αS was kept
constant at 10 µM whereas the concentrations of SUV-0% and SUV-31% were calculated by considering exclusively the DOPE:DOPS:DOPC component in both
types of vesicles. (B,C) CD titration in 20 mM buffer, pH 6.0 measured at 10◦C for SUV-0% (B) and SUV-31% (C). (D,E) Fitting of the CD titrations following the
signal at 222 nm, [θ]222 nm for SUV-0% (D) and SUV-31% (E). The Hill equation was used to account for both binding constant KD and the cooperativity, which is
fitted with the Hill coefficient n.
SDS-PAGE and the protein concentration was determined from
the absorbance at 275 nm using an extinction coefficient
of 5600 M−1 cm−1.
Preparation of SUVs
We prepared two types of small unilamellar vesicles (SUVs).
One SUV type was made using a mixture of DOPE:DOPS:DOPC
lipids (Avanti Polar Lipids Inc., Alabaster, United States) in
a ratio of 5:3:2 w/w. A second type of vesicles was prepared
using DOPE:DOPS:DOPC lipids (5:3:2 w/w) and non-esterified
cholesterol, the latter amounting to 31% w/w of the total mixture
to mimic its natural abundance in the membrane component of
SVs (Takamori et al., 2006). We denoted the two vesicle types
as SUV-0% and SUV-31%. These SUVs were prepared from
chloroform solutions as described previously (Bodner et al., 2009;
Fusco et al., 2014). Briefly, the lipid mixture was evaporated
under a stream of nitrogen gas and then dried thoroughly under
vacuum to yield a thin lipid film. The dried thin film was
then re-hydrated by adding aqueous buffer (20 mM sodium
phosphate, pH 6.0) at a concentration of 10 mg.ml−1 (1.5%) and
subjected to vortex mixing. In all NMR experiments described
in this paper SUVs were obtained by using several cycles of
freeze-thawing and sonication until the mixture became clear
(Bodner et al., 2009; Fusco et al., 2014) and followed by a
step of extrusion through membranes using pore diameters of
50 nm (Avanti Polar Lipids, Inc.). All SUVs were controlled with
dynamic light scattering (DLS) in order to obtain vesicles with the
same average size.
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Chemical Exchange Saturation Transfer
(CEST) Experiments
Chemical Exchange Saturation Transfer (CEST) measurements
in solution NMR (Milojevic et al., 2007; Huang et al., 2008;
Fawzi et al., 2011; Vallurupalli et al., 2012; Fusco et al., 2014;
Romano et al., 2018) probed the equilibrium between membrane
unbound and membrane bound states of αS via direct detection
of saturation in the resonances of the unbound state. In
studying αS-SUV interactions, CEST shows higher sensitivity
than measurements based on the signal attenuation in HSQC
spectra, and enables measurements at low lipid:protein ratios to
minimize αS or lipid aggregation (Fusco et al., 2014). Moreover,
CEST signals are directly sensitive to the interaction between
αS and the membrane surface and disclose the interference
from additional factors that can contribute to the transverse
relaxation rates of the protein resonances (Milojevic et al.,
2007; Huang et al., 2008; Fawzi et al., 2011; Vallurupalli et al.,
2012). CEST was carried out at 10◦C on a sample composed
of αS (300 µM) incubated with SUV-31% at a concentration
of 0.6 mg/ml in 20 mM sodium phosphate buffer at pH 6.0,
and using a Bruker spectrometer operating at 1H frequencies of
700 MHz equipped with triple resonance HCN cryo-probe. These
experiments were based on 1H-15N HSQC spectra by applying
constant wave saturation in the 15N channel. Assignment of
the solution NMR resonances was obtained from our previous
studies (Fusco et al., 2014) and controlled with a series of 3D
spectra by following a published protocol (Fusco et al., 2012).
Since we aimed at probing the exchange between monomeric
αS (having sharp resonances) and αS bound to SUVs (having
significantly broader resonances), a series of large offsets was
employed (−28, −21, −14, −9, −5, −3, −1.5, 0, 1.5, 3, 5, 9,
14, 21, and 28 kHz), resulting in CEST profiles of symmetrical
shapes (Huang et al., 2008; Fawzi et al., 2011; Fusco et al.,
2014). An additional spectrum, saturated at −100 kHz, was
recorded as a reference. The CEST experiments were measured
using a data matrix consisting of 2048 (t2, 1H) × 220 (t1,
15N) complex points.
Transverse Relaxation Experiments
Standard pulse sequences were used for T2 experiments (Farrow
et al., 1994), including the watergate sequence (Piotto et al., 1992)
to improve water suppression. T2 values were obtained by fitting
single exponential decays to the experimental data; the fitting of
experimental data and the error analyses were performed with
the program SPARKY. Relaxation was measured at 10◦C on a
sample composed of αS (300 µM) incubated with SUV-31% at
a concentration of 0.6 mg/ml and using a Bruker spectrometer
operating at 1H frequencies of 700 MHz equipped with triple
resonance HCN cryo-probe. Assignment of the solution NMR
resonances was obtained from our previous studies (Fusco et al.,
2014) and controlled with a series of 3D spectra by following a
published protocol (Fusco et al., 2012).
Dynamic Light Scattering (DLS)
Dynamic Light Scattering measurements of vesicle size
distributions were performed using a Zetasizer Nano ZSP
instrument (Malvern Instruments, Malvern, United Kingdom)
with backscatter detection at a scattering angle of 173◦. The
viscosity (0.8882 cP) and the refractive index (1.330) of water
were used as parameters for the buffer solution, and the
material properties of the analyte were set to those of the
lipids (absorption coefficient of 0.001 and refractive index
of 1.440). SUVs were used at a concentration of 0.05% in
these measurements and the experiments were performed
at 25◦C. The acquisition time for the collection of each
dataset was 10 sec and accumulation of the correlation curves
was obtained using 10 repetitions. Each measurement was
repeated 10 times to estimate standard deviations and average
values of the centers of the size distributions. Samples used
in DLS measurements were incubated, with or without αS
molecules for 1 h at 298 K using freshly prepared samples
of SUV-0% and SUV-31% at a concentration of 0.05%. The
concentrations of SUV-0% and SUV-31% were calculated by
considering exclusively the DOPE:DOPS:DOPC component
in both types of vesicles. Moreover, in order to compensate
for the 2.6 times difference in KD, the concentration of αS
was 77 µM and 200 µM when incubated with SUV-0% and
SUV-31%, respectively.
Circular Dichroism Analysis of αS in the
Presence of Different Concentrations of
SUVs
Circular Dichroism (CD) measurements were made at 10◦C.
CD samples were prepared in 20 mM sodium phosphate buffer
at pH 6.0, by using a constant concentration of αS (10 µM)
and variable concentrations of SUV-0% and SUV-31%. The SUV
concentrations were calculated by considering exclusively the
DOPE:DOPS:DOPC component in both types of vesicles. Far-
UV CD spectra were recorded on a JASCO J-810 equipped with
a Peltier thermally controlled cuvette holder. Quartz cuvettes
with path lengths of 1 mm were used, and CD spectra were
obtained by averaging ten individual spectra recorded between
250 nm and 200 nm with a bandwidth of 1 nm, a data pitch
of 0.2 nm, a scanning speed of 50 nm/min and a response
time of 4 s. Each value of the CD signal intensity reported
at 222 nm corresponds to the average of ten measurements.
For each protein sample, the CD signal of the buffer used to
solubilize the protein was recorded and subtracted from the CD
signal of the protein.
Cryo-Electron Microscopy (Cryo-EM)
Measurements
All samples used in cryo-EM measurements were incubated,
with or without αS (200 µM), for 1 h at 298K using fresh
preparations of SUV-31% at a concentration of 0.05%. The
SUV concentrations were calculated by considering exclusively
the DOPE:DOPS:DOPC component. After incubation cryo-
EM grids were prepared by vitrifying the sample solutions
using aliquots of 2 µL and a Vitrobot Mark III apparatus
(SMIF, Duke University, Durham, United Kingdom) at a relative
humidity of 100% at 20◦C. The samples were loaded on a
glow-discharged copper Quantifoil R2/2 grid (Quantifoil GmbH,
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Germany) and blotted with filter paper for 2.5 s to leave a
thin film of solution. The blotted samples were immediately
plunged into liquid ethane and stored under liquid nitrogen
prior to imaging. Micrographs were aquired using a Tecnai
T12 twin (LaB6) electron microscope operating at 120 kV (FEI,
Hillsboro, Oregon, United States), using a Gatan 626 cryo-holder
(Gatan, Pleasanton, United States) cooled with liquid nitrogen to
temperatures below -170◦C. Digital micrographs were acquired
on a TVIPS F216 CCD camera using the EMMENU 4 software
package (TVIPS, Munich, Germany).
RESULTS
Influence of Cholesterol on the Binding
Affinity of αS With Synaptic-Like SUVs
We used synaptic-like small unilamellar vesicles (SUVs)
composed of a mixture of 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-
3-phospho-L-serine (DOPS), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) at a ratio w/w of 5:3:2 (Bodner
et al., 2009). This mixture has been widely used to study the
binding of αS with synaptic membranes (Bodner et al., 2009,
2010; Maltsev et al., 2012; Ouberai et al., 2013; Fonseca-Ornelas
et al., 2014; Fusco et al., 2014, 2016b; Ysselstein et al., 2015), and
is considered to be a good model of SV membrane in terms of
curvature, charge and lipid composition (Bodner et al., 2009).
A second type of SUVs was prepared using DOPE:DOPS:DOPC
lipids (5:3:2 w/w) and cholesterol, the latter amounting to 31%
w/w of the total mixture to mimic the natural abundance in
the membrane component of SVs (Takamori et al., 2006). The
two types of vesicles are denoted as SUV-0% and SUV-31%
throughout this article.
We first characterized the binding affinity using CD to probe
the overall conformational transition of αS upon interaction with
the SUVs. In aqueous solution, the CD spectrum of αS is typical
of a random coil protein, whereas upon incubation with acidic
SUVs the spectrum adopts the characteristic shape measured
for α-helical proteins (Fusco et al., 2014). We performed CD
measurements of αS in the presence of different concentrations
the SUVs to probe the transition from disorder-unbound to
α-helical-bound states of the protein, as monitored at 222 nm,
[θ]222. The data indicate that cholesterol affects the binding
properties of αS, resulting in weaker interactions with SUV-31%
than SUV-0% (Figures 1B,C). We used the Hill equation to
fit the CD titrations and to calculate an apparent dissociation
constant, KD:
χB = [Lipid]
n
KD + [Lipid]n
where χB is the fraction of bound helix probed at [θ]222, KD is
the apparent dissociation constant, and n is the Hill coefficient
describing the cooperativity of the process. The results indicate
that both vesicle compositions here analyzed are bound by
αS with a significant level of cooperativity, as indicated by n
coefficients larger than 1 (2.11± 0.14 and 2.03± 0.17 for SUV-0%
and SUV-31%, respectively). By contrast, the apparent binding
constants KD indicate that the membrane affinity of αS is 2.6
times stronger for SUV-0% (0.376 ± 0.03 mM) than SUV-31%
(0.972 ± 0.09 mM, Figures 1D,E). The effect of cholesterol
was further investigated by performing CD titrations made with
intermediate concentrations of the molecule in the SUV mixture,
namely 10% and 20% w/w. Overall, a linear correlation was found
between the amount of cholesterol and the resulting KD within
the range of 0–31% w/w (Supplementary Figure S1).
It is worth noting that in SUV-31% the fraction of charged
components (DOPS) in the total mixture is reduced because
of the presence of an additional non-charged component
(cholesterol). Since negative charges play a key role in membrane
binding by αS, we decoupled the charge effect from the results
of our affinity measurements. This was achieved by considering
only the DOPE:DOPS:DOPC component in the calculation of
the SUV concentrations, which provided consistent αS:DOPS
ratios in the CD titrations made with the two types of
vesicles. Indeed, the inclusion of cholesterol in the calculation
of SUV-31% concentrations would result in significantly weaker
binding affinities as a consequence of the lower αS:DOPS ratios
(Supplementary Figure S2). In order to further investigate the
charge effect associated with the presence of cholesterol in the
lipid mixture, we measured the affinity of αS for modified SUV-
31% in which cholesterol is substituted by another non-charged
component (POPE) (Supplementary Figure S3). The results
show a binding affinity that is significantly stronger than that of
SUV-31% and very close to that of SUV-0%. This result indicates
that the charge effect is not a determining factor in the low
affinity of SUV-31%.
Structural Properties of αS Bound to
Synaptic-Like SUVs Containing
Cholesterol
We then used CEST in solution NMR spectroscopy (Milojevic
et al., 2007; Huang et al., 2008; Fawzi et al., 2011; Vallurupalli
et al., 2012; Fusco et al., 2014; Romano et al., 2018) to probe
the equilibrium between membrane bound and unbound states
of αS at the resolution of individual amino acid residues. CEST
has been used to accurately characterize the equilibrium between
membrane unbound (detectable in solution-NMR spectroscopy)
and membrane bound (undetectable) states of αS (Fusco et al.,
2014, 2016b). By applying a continuous weak radiofrequency
field off-resonance (up to ± 28 kHz) in the 15N channel, it is
possible to selectively saturate the membrane-bound state of the
protein (Milojevic et al., 2007; Huang et al., 2008; Fawzi et al.,
2011; Vallurupalli et al., 2012; Fusco et al., 2014; Romano et al.,
2018). This saturation is then transferred via chemical exchange
to the unbound state and detected as an attenuation of the signal
intensities of the protein residues, thereby directly probing the
strength of membrane interaction.
Chemical exchange saturation transfer was measured using
a sample composed of αS (300 µM) incubated with SUV-
31% (0.6 mg/ml) with two different continuous-wave radio
frequencies (170 Hz and 350 Hz, Figures 2A,B). The data
showed strong saturation in the N-terminal region of the
protein, indicating significant affinity for lipid membranes,
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FIGURE 2 | Conformational properties of αS binding to acidic SUVs. (A–D) CEST experiments were recorded at a 1H frequency of 700 MHz (see section “Materials
and Methods”), using a protein concentration of 300 µM and 0.06% (0.6 mg/ml) of SUV-31%. The concentration of SUV-31% was calculated by considering
exclusively the DOPE:DOPS:DOPC component of the lipid mixture. 1H-15N CEST spectra were recorded by using a continuous wave saturation (170 Hz or 350 Hz)
on the 15N channel at a range of offsets: −28, −21, −14, −9, −5, −3, −1.5, 0, 1.5, 3, 5, 9, 14, 21, and 28 kHz. An additional spectrum saturated at –100 kHz was
recorded as a reference. CEST surface was measured using a saturation bandwidth of 350 Hz (A) and 170 Hz (B) and the saturation along the αS sequence (350 Hz
and 170 Hz in panels (C,D), respectively) is shown. Black, orange and green lines refer to the averaged CEST profiles measured using offsets at ± 1.5 kHz,
± 3.0 kHz, and ± 5.0 kHz, respectively. (E) T2 values from transverse relaxation measurements [experimental conditions as in panels (A–D)]. The pink background in
panels (C–E) evidences region 65–97, where a reduction in binding compared to the preceding segment is observed in both CEST (reduced saturation) and
relaxation (higher T2 values) measurements.
whereas saturation then gradually decreased from residue 26–97,
indicating a progressive reduction in the membrane affinity of
the central region of αS (Figures 2A–D). Finally, the C-terminal
segment (98–140) resulted very weakly associated with the
membrane as shown by very low CEST saturation values. By
comparing these results with CEST profiles previously measured
using SUV-0% (Fusco et al., 2014), the only significant difference
in the two measurements was found in the region spanning
residues 65–97, with weaker local binding for acidic SUVs
containing cholesterol (Figures 2C,D). We analyzed the CEST
saturations measured using a bandwidth of 350 Hz at offsets
of ± 1.5 kHz to provide a quantitative estimation of the
population of states in the membrane-bound αS featuring the
detachment of the region 65–97 from the lipid bilayer (state
B∗ in Figure 3A) in contrast to conformations featuring a
fully bound region 65–97 (state B in Figure 3A). The data
indicate that the population of B∗ states is 38%, when the
αS interacts with SUV-0% and rises to 51% in the case of
SUV-31%. The shift toward unbound populations in the region
65–97 is consistent with transverse relaxation measurements
(Figure 2E) showing high T2 values for this region upon
interaction with SUV-31%.
Influence of Cholesterol on the
Vesicle-Vesicle Interactions Promoted
by αS
Our previous study based on the familial mutations of αS
indicated that the membrane binding modes of the region
65–97 and of the N-terminal anchor have some degree of
independence, leading to the suggestion that, in addition to
interacting with a single membrane surface, these two regions
can also bind simultaneously two different vesicles and induce
their interaction (Fusco et al., 2016b; Figure 3A). This “double-
anchor” mechanism was confirmed by a mutant of αS designed to
have higher efficiency in mediating vesicle-vesicle interactions as
a result of an enhanced exposure of the region 65–97, as observed
both using synaptic-like SUVs and ex vivo SVs (Fusco et al.,
2016b). This evidence indicated that the detachment of the region
65 to 97 from the membrane surface is a dominant factor to
Frontiers in Neuroscience | www.frontiersin.org 6 January 2020 | Volume 14 | Article 18
fnins-14-00018 January 27, 2020 Time: 15:58 # 7
Man et al. Cholesterol Reduces the Membrane-Binding Affinity of α-Synuclein
FIGURE 3 | Cholesterol enhances vesicle-vesicle interactions promoted by αS. (A) Schematic representation of the SUV binding modes of αS and the
double-anchor mechanism for vesicle-vesicle interactions (Fusco et al., 2016b). Upon binding to acidic SUVs, αS adopts an ensemble conformation (center). Two
major conformational states are shown in the scheme, namely a fully α-helical state spanning the whole region 1–97 (state B) bound to the same membrane and a
state B∗ that interacts with the membrane exclusively through the N-terminal anchor (residues 1–25), with the rest of the protein being detached from the membrane
surface. The state B∗ is an active conformation for the recruitment of a second vesicle through the double-anchor mechanism (Fusco et al., 2016b) (right), with a
single αS molecule binding two vesicles via its N-terminal region (lower vesicle) and the region 65–97 (upper vesicle). The population of B∗ measured using CEST
experiments was found to increase from 38% to 51% when interacting with SUV-0% and SUV-31%, respectively. Color codes for the regions of αS are blue (1–25),
gray (26–64), green (65–97), and red (98–140). (B) Examples of isolated (left) and fused (right) SUV-31%, as probed from images obtained in vitro by cryo-EM, the
scale bar is 50 nm. (C) DLS measurements of SUVs, either isolated or incubated with αS. Samples used in DLS measurements were incubated, with or without αS
molecules, for 1 h at 298 K using freshly prepared SUVs at a concentration of 0.05% and made with SUV-0% and SUV-31%. The SUV concentrations were
calculated by considering the DOPE:DOPS:DOPC component exclusively in both types of vesicles. In order to compensate for the 2.6 difference in KD, the
concentrations of αS when incubated with SUV-0% and SUV-31%, were 77 µM and 200 µM, respectively, which enables to decouple the differences in the binding
affinities from the tendency to promote vesicle fusion. Each measurement was made of 10 replicates. Error bars report standard deviations of the centers of the size
distributions in the 10 replicates. The single (*) and double (**) asterisks indicate P = 0.9264 and P = 0.01, respectively. These were calculated using the unpaired
t-test with Welch’s correction (Sawilowsky, 2002).
promote αS-induced vesicle-vesicle interactions, and overcomes
the loss of local membrane binding affinity. In accordance with
the double-anchor mechanism, the deletion of the segment 71–
82 and the weakening of the membrane affinity of the N-terminal
anchor region were found to impair vesicle clustering by αS in
S. cerevisiae (Soper et al., 2008).
Since the present NMR results indicate a weaker association of
the region 65–97 to cholesterol-containing SUVs, we tested the
promotion of clustering of these vesicle induced by αS. When
synaptic-like SUVs are used in vitro, vesicle-vesicle interactions
promoted by αS result in vesicle fusion (Bodner et al., 2009; Fusco
et al., 2016b; Figure 3B), a process that can be monitored both
at a single vesicle level or in bulk measurements (Fusco et al.,
2016b). We used here a previously optimized protocol (Fusco
et al., 2016b) based on bulk experiments of DLS to monitor
how the average size of SUV-0% and SUV-31% is affected by
the interaction with αS (Figure 3C). In estimating vesicle fusion
promoted by αS, DLS has proved to be an accurate and fast
method, generating results that are in agreement with super-
resolution STED imaging but with the advantage of performing
measurements in bulk solution (Fusco et al., 2016b). In the
absence of αS the two types of vesicles were prepared with the
same average size (43.9 ± 2.7 nm and 43.7 ± 3.3 nm for SUV-
0% and SUV-31%, respectively, P value of 0.93). The sizes of
both vesicle samples, however, increased when incubated with
αS (56 ± 5 nm and 62 ± 4 nm for SUV-0% and SUV-31%,
respectively, P value of 0.01). These data therefore confirm
the previous observations obtained with SUV-0% (Fusco et al.,
2016b) and also indicate that the presence of cholesterol alters
the conformation of the membrane-bound αS as well as its
ability to induce the interaction and fusion of acidic vesicles
containing cholesterol. This effect is likely to arise from an
enhanced population of B∗ states at the surface SUV-31%, which
is the active conformation for the double-anchor mechanism
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promoting vesicle-vesicle interactions (Figure 3A). A similar
effect was indeed previously observed using a designed mutant
of αS that promotes enhanced detachment of the region 65–97
from the surface of SUV-0% as well as stronger vesicle-vesicle
interactions (Fusco et al., 2016b).
DISCUSSION
In this work, we have investigated how cholesterol affects the
equilibrium between cytosolic and membrane-bound states of
αS. This equilibrium is crucial for the physiological properties
of this protein (Fusco et al., 2018), as well as the kinetics of
αS aggregation (Perrin et al., 2001; Necula et al., 2003; Sharon
et al., 2003; Zhu and Fink, 2003; Auluck et al., 2010; Comellas
et al., 2012) and the toxicity of the resulting aggregates (Winner
et al., 2011; Lorenzen et al., 2014; Fusco et al., 2017). Cholesterol
is a key component of the membrane of SVs (Takamori et al.,
2006), and is expected to influence the membrane binding of αS.
We therefore aimed at characterizing the membrane interaction
of αS under conditions resembling as close as possible the
physiological properties of SV membranes. The relationship
between cholesterol and PD is highly debated in the literature
(Bosco et al., 2006; Liu et al., 2010), with several observations
indicating a link between αS and the levels of cholesterol in
cellular membranes (Fantini et al., 2011; van Maarschalkerweerd
et al., 2014; Hsiao et al., 2017). Cholesterol was shown in
particular to enhance the propensity of αS to induce the
formation of defects in lipid bilayers (Pan et al., 2018), whereas αS
can remodel cholesterol-enriched ternary membranes that mimic
cellular raft-like domains (Leftin et al., 2013).
Our data indicate that the presence of cholesterol in the
lipid bilayer reduces the overall binding affinity for synaptic-
like vesicles, a result in agreement with studies in yeast showing
that the inhibition of sterol synthesis enhances the vesicular
localization of αS (Valastyan et al., 2014). A detailed analysis
based on NMR CEST and relaxation experiments indicated that
the structural effect of cholesterol on the membrane interaction
by αS is restricted to residues in the NAC region, indicating
a link between the overall binding affinity of the protein and
the local interactions of the region 65–97. Similarly, the high
binding affinity of αS for POPG SUVs, three times stronger
than the binding with SUV-0%, was attributed to the strong
local interaction of the central region of the protein (Fusco
et al., 2014). Taken together these data support the emerging
idea that the central region of αS plays the role of a membrane
sensor that determines the overall binding affinity for lipid
membranes. We also found that the double-anchor mechanism,
which promotes vesicle-vesicle interactions by αS, is enhanced
in the presence of cholesterol, thus providing new evidence that
the exposure of the region 65–97 in the membrane-bound state
of αS is crucial for inducing vesicle clustering (Fusco et al.,
2016b). In addition to the possibility that a broken α-helix
structure, which is a conformation that αS adopts upon binding
with detergent micelles (Ulmer and Bax, 2005; Mazumder et al.,
2013), can be involved in the promotion of vesicle-vesicle
interactions (Dikiy and Eliezer, 2012; Snead and Eliezer, 2014),
our data indicate that the balance between membrane-bound
(ordered) and membrane-detached (disordered) species in the
region 65–97 is indeed the crucial modulator of the ability of
αS to bridge multiple vesicles and induce their clustering. It
is worth noting that our work focuses specifically on the αS-
membrane interaction, however, protein-protein interactions at
the surface of SV, including binding with VAMP-2 (Burre et al.,
2010; Diao et al., 2013) and Rab3a (Chen et al., 2013), are
also crucial for the regulation of SV trafficking. The binding
of αS with the membrane and protein components of SV can
have cooperative effects, as shown in studies in synaptosomes,
where high concentrations of Ca2+ were correlated with both an
enhanced double-anchor mechanism and a strong colocalization
with VAMP-2 (Lautenschlager et al., 2018).
The highlighted region 65–97 of αS is also known to span most
of the NAC sequence, a region that has been largely associated
with the mechanisms of αS aggregation (Cookson, 2005; Chiti
and Dobson, 2006; Rodriguez et al., 2015). The present study
provides further evidence that the NAC region may not only act
as the most amyloidogenic region of αS, but also have a functional
relevance. Perturbations in the local membrane interactions of
residues in the NAC, as we have observed here as a result of
the presence of cholesterol in the lipid bilayer, can significantly
alter the properties of the membrane-bound state of αS, including
its overall binding affinity and the ability to induce vesicle-
vesicle interactions.
In conclusion our study has identified the structural basis
of the modulation of the membrane binding affinity of αS by
cholesterol. We found that the fine-tuning between bound and
unbound conformations in the NAC region is a key element
modulating the behavior of αS at the surface of synaptic-
like membranes. Perturbations of this balance are expected
to generate aberrant protein-protein interactions leading to
membrane-induced aggregation (Auluck et al., 2010; Grey et al.,
2011, 2015; Comellas et al., 2012) or to impair some functional
conformations that play a role in the normal physiological
state of αS.
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